Curo360 Lifesciences Private Limited

Clotrimazole vaginal gel is an antifungal medication used to treat vaginal fungal infections, commonly referred to as vaginal thrush or yeast infections. Its primary uses include:

• Treating vaginal yeast infections (vulvovaginal candidiasis).
• Relieving associated symptoms such as vaginal burning, itching, pain, and abnormal white discharge.
• Stopping the growth of the fungi (typically Candida species) that cause the infection by damaging their cell membranes. 

Important Considerations:

• Clotrimazole is an antifungal agent and is not effective against bacterial or viral infections. For mixed infections, a doctor may prescribe a combination gel containing both an antifungal and an antibiotic.
• It is generally available over-the-counter or with a prescription, but should be used as directed by a healthcare professional.
• The medication should be used for the full course of treatment, even if symptoms improve earlier, to ensure the infection is fully cleared.
• Do not use tampons or other vaginal products during treatment.
• Avoid sexual intercourse until the infection has cleared to prevent spreading it to a partner. 

If symptoms do not improve within a few days, last longer than a week, or if you experience severe side effects, you should consult a doctor for proper diagnosis and treatment. 

Additional Information:

• Production Capacity: GOOD
• Delivery Time: IMMEDIATE
• Packaging Details: 30GM

Qrosteron Gel Vaginal gel contains progesterone, a female hormone that is important in the regulation of ovulation and menstruation. It is used to cause menstrual periods in women who have not reached menopause but are not having periods due to a lack of natural progesterone in the body.
Qrosteron Gel  (progesterone) gel is a bioadhesive vaginal gel contained in single-use, one-piece polyethylene vaginal applicators. Crinone is indicated as treatment for infertile women with progesterone deficiency and women with secondary amenorrhea

• sudden headache, numbness or weakness (especially on one side of the body):
• shortness of breath, or problems with vision, speech, or balance;
• chest pain or heavy feeling, pain spreading to the arm or shoulder;
• pain or swelling in one or both legs;
• stomach pain, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
• swelling in your hands, ankles, or feet;
• fever, chills, body aches, flu symptoms;
• a breast lump; or
• symptoms of depression (sleep problems, weakness, mood changes).progesterone) gel Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

• (progesterone gel) is a bioadhesive vaginal gel containing micronized progesterone in an emulsion system, which is contained in single use, polypropylene vaginal applicators. The carrier vehicle is an oil in water emulsion containing the water swellable, but insoluble polymer, polycarbophil. The progesterone is partially soluble in both the oil and water phase of the vehicle, with the majority of the progesterone existing as a suspension. Physically, Crinone has the appearance of a soft, white to off-white gel.

  The active ingredient, progesterone, is present in either a 4% or an 8% concentration (w/w). The chemical name for progesterone is pregn-4-ene-3,20-dione. It has an empirical formula of C21H30O2 and a molecular weight of 314.5.

• Progesterone exists in two polymorphic forms. Form 1, which is the form used in Crinone, exists as white orthorhombic prisms with a melting point of 127-131°C.

  Each applicator delivers 1.125 grams of Crinone gel containing either 45 mg (4% gel) or 90 mg (8% gel) of progesterone in a base containing glycerin, light mineral oil, polycarbophil, carbomer homopolymer Type B, hydrogenated palm oil glyceride, sorbic acid, purified water and may contain sodium hydroxide.

• Progesterone exists in two polymorphic forms. Form 1, which is the form used in Crinone, exists as white orthorhombic prisms with a melting point of 127-131°C.

  Each applicator delivers 1.125 grams of Crinone gel containing either 45 mg (4% gel) or 90 mg (8% gel) of progesterone in a base containing glycerin, light mineral oil, polycarbophil, carbomer homopolymer Type B, hydrogenated palm oil glyceride, sorbic acid, purified water and may contain sodium hydroxide.

• Progesterone exists in two polymorphic forms. Form 1, which is the form used in Crinone, exists as white orthorhombic prisms with a melting point of 127-131°C.

  Each applicator delivers 1.125 grams of Crinone gel containing either 45 mg (4% gel) or 90 mg (8% gel) of progesterone in a base containing glycerin, light mineral oil, polycarbophil, carbomer homopolymer Type B, hydrogenated palm oil glyceride, sorbic acid, purified water and may contain sodium hydroxide.

• 4% gel (45 mg) in a single use, disposable, white polypropylene vaginal applicator with a teal twist-off cap. Each applicator contains 1.3 g of gel and delivers 1.125 g of gel.

• NDC 52544-255-24: 6 Single-use prefilled applicators.

  8% gel (90 mg) in a single use

Additional Information:

• Production Capacity: 2000
• Delivery Time: immidate
• Packaging Details: 1*15